These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8618579)

  • 21. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
    Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of ARDS with two doses of synthetic surfactant.
    Heikinheimo M; Hynynen M; Rautiainen P; Andersson S; Hallman M; Kukkonen S
    Chest; 1994 Apr; 105(4):1263-4. PubMed ID: 8162762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient.
    Perez-Benavides F; Riff E; Franks C
    Pediatr Emerg Care; 1995 Jun; 11(3):153-5. PubMed ID: 7651868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus on surfactant and inhaled nitric oxide for ARDS.
    Gadek JE
    J Aerosol Med; 1996; 9(1):155-62. PubMed ID: 10160205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.
    Anzueto A; Jubran A; Ohar JA; Piquette CA; Rennard SI; Colice G; Pattishall EN; Barrett J; Engle M; Perret KA; Rubin BK
    JAMA; 1997 Nov; 278(17):1426-31. PubMed ID: 9356001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure.
    Thomas NJ; Guardia CG; Moya FR; Cheifetz IM; Markovitz B; Cruces P; Barton P; Segal R; Simmons P; Randolph AG;
    Pediatr Crit Care Med; 2012 Nov; 13(6):646-53. PubMed ID: 22791092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 32. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
    Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
    Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
    J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
    Billman D; Nicks J; Schumacher R
    Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of exogenous surfactant in acute lung injury.
    Lewis JF; Brackenbury A
    Crit Care Med; 2003 Apr; 31(4 Suppl):S324-8. PubMed ID: 12682460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Sell M; Cotton R; Hirata T; Guthrie R; LeBlanc M; Mammel M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.
    Bernard GR; Wheeler AP; Russell JA; Schein R; Summer WR; Steinberg KP; Fulkerson WJ; Wright PE; Christman BW; Dupont WD; Higgins SB; Swindell BB
    N Engl J Med; 1997 Mar; 336(13):912-8. PubMed ID: 9070471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V
    Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.